APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | -48.4% | 350 | -36.1% | 0.00% | 0.0% |
| Q4 2020 | $31,000 | +138.5% | 548 | +31.1% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | +18.2% | 418 | +21.9% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | -71.1% | 343 | -75.9% | 0.00% | -66.7% |
| Q1 2020 | $38,000 | -33.3% | 1,421 | -23.4% | 0.00% | -25.0% |
| Q4 2019 | $57,000 | – | 1,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |